SMC - March 2022 decisions

SMC

7 March 2022 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today published advice on seven new medicines.

Three of the medicines accepted, sacituzumab govitecan (Trodelvy), sotorasib (Lumykras) and lorlatinib (Lorviqua), were awarded Innovation Passports within the new Innovative Licensing and Access Pathway.

Read SMC press release 

Michael Wonder

Posted by:

Michael Wonder